Startup Nabs $25 Million Series A , Forms A World-Renowned Team Of Academics And Clinicians

CRISPR Therapeutics Raises $25 Million in Series A Financing and Announces Founding Team of World-Renowned Academics and Clinicians BASEL, Switzerland-- --CRISPR Therapeutics, a biopharmaceutical company focused on the breakthrough gene-editing technology CRISPR-Cas9, has raised $25 million in a series A investment from Versant Ventures.

http://ift.tt/1jV1q77